Botanix Pharmaceuticals' market value is the price at which a share of Botanix Pharmaceuticals trades on a public exchange. It measures the collective expectations of Botanix Pharmaceuticals Limited investors about its performance. Botanix Pharmaceuticals is trading at 0.0789 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0789. With this module, you can estimate the performance of a buy and hold strategy of Botanix Pharmaceuticals Limited and determine expected loss or profit from investing in Botanix Pharmaceuticals over a given investment horizon. Check out Botanix Pharmaceuticals Correlation, Botanix Pharmaceuticals Volatility and Botanix Pharmaceuticals Alpha and Beta module to complement your research on Botanix Pharmaceuticals.
Please note, there is a significant difference between Botanix Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Botanix Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Botanix Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Botanix Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Botanix Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Botanix Pharmaceuticals.
0.00
11/26/2025
No Change 0.00
0.0
In 30 days
12/26/2025
0.00
If you would invest 0.00 in Botanix Pharmaceuticals on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding Botanix Pharmaceuticals Limited or generate 0.0% return on investment in Botanix Pharmaceuticals over 30 days. Botanix Pharmaceuticals is related to or competes with Innate Pharma, NDT Pharmaceuticals, Molecular Partners, Scancell Holdings, Brii Biosciences, JW (Cayman), and Hofseth BioCare. Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Aus... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Botanix Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Botanix Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Botanix Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Botanix Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Botanix Pharmaceuticals historical prices to predict the future Botanix Pharmaceuticals' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Botanix Pharmaceuticals. Your research has to be compared to or analyzed against Botanix Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Botanix Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Botanix Pharmaceuticals.
Botanix Pharmaceuticals Backtested Returns
Botanix Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.034, which signifies that the company had a -0.034 % return per unit of risk over the last 3 months. Botanix Pharmaceuticals Limited exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Botanix Pharmaceuticals' Downside Deviation of 19.56, mean deviation of 4.38, and Risk Adjusted Performance of 0.0295 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Botanix Pharmaceuticals will likely underperform. At this point, Botanix Pharmaceuticals has a negative expected return of -0.32%. Please make sure to confirm Botanix Pharmaceuticals' maximum drawdown, as well as the relationship between the semi variance and rate of daily change , to decide if Botanix Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.91
Near perfect reversele predictability
Botanix Pharmaceuticals Limited has near perfect reversele predictability. Overlapping area represents the amount of predictability between Botanix Pharmaceuticals time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Botanix Pharmaceuticals price movement. The serial correlation of -0.91 indicates that approximately 91.0% of current Botanix Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.91
Spearman Rank Test
0.36
Residual Average
0.0
Price Variance
0.0
Botanix Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Botanix Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Botanix Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Botanix Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Botanix Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Botanix Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Botanix Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Botanix Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Botanix Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Botanix Pharmaceuticals Lagged Returns
When evaluating Botanix Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Botanix Pharmaceuticals pink sheet have on its future price. Botanix Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Botanix Pharmaceuticals autocorrelation shows the relationship between Botanix Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Botanix Pharmaceuticals Limited.
Other Information on Investing in Botanix Pink Sheet
Botanix Pharmaceuticals financial ratios help investors to determine whether Botanix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Botanix with respect to the benefits of owning Botanix Pharmaceuticals security.